In a mice model of NASH-related HCC, abundance of CD8+PD1+ T cells augments, however, anti-PD1 immunotherapy fails to restrain the progression of HCC and even results in a significant increase in the incidence of HCC (139). This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.